Introduction {#sec1-1}
============

Superficial non-ampullary duodenal epithelial tumors (SNADET) are uncommonly encountered during upper endoscopy as opposed to ampullary tumors \[[@ref1]\]. However, the incidence of non-ampullary adenomas and duodenal adenocarcinoma is increasing. A multicenter study conducted in Japan from 2007-2012 showed 396 SNADET resected lesions in 364 patients \[[@ref2]\]. The incidence increased 2-fold over the study duration (from first to second half) and the incidence of duodenal adenocarcinoma increased 3-fold.

There is no standardized technique for endoscopic resection of SNADET. Endoscopic mucosal resection (EMR) with submucosal injection and endoscopic submucosal dissection (ESD) are commonly utilized. EMR has been shown to have a superior safety profile; however, this technique has the disadvantage of lower rates of complete initial resection, requiring multiple endoscopy sessions, and a recurrence rate of up to 37% \[[@ref3]\]. In contrast, ESD has been shown to be superior regarding the rate of complete resection. However, ESD has limited experience in western countries and is associated with higher rates of perforation \[[@ref4]\].

Underwater EMR (UEMR) is an emerging technique for endoscopic resection. This technique was first described by Binmoeller *et al* for mucosal resection of large colonic polyps \[[@ref5]\]. UEMR for colonic polyps has been shown to be superior to traditional EMR with submucosal injection in terms of macroscopic resection and local recurrence \[[@ref6]\]. In addition, subsequent studies have shown that UEMR has low rates of adverse events and self-limited delayed bleeding \[[@ref7]\]. UEMR has been more recently described for the endoscopic resection of SNADET. The purpose of our study was to perform a systematic review and meta-analysis of the available literature to evaluate the efficacy and safety of UEMR for SNADET.

Materials and methods {#sec1-2}
=====================

Search strategy {#sec2-1}
---------------

We conducted a comprehensive search of several databases from inception to August 2019. An experienced medical librarian assisted with the literature search. The databases searched were as follows: Ovid Cochrane Database of Systematic Reviews, Ovid Embase, Scopus, Ovid Cochrane Central Register of Controlled trials, Ovid MEDLINE^®^, and In-Process and other non-indexed citations. Controlled vocabulary supplemented with keywords was used to search for studies of interest. The full search strategy is available in [Appendix1](#App1){ref-type="app"}. The PRISMA and MOOSE checklists were followed and are provided in [Appendices 2](#App2){ref-type="app"} and [3](#App3){ref-type="app"} \[[@ref8],[@ref9]\].

Study selection {#sec2-2}
---------------

In this meta-analysis, we included studies that evaluated the clinical outcomes of UEMR. Studies were included regardless of sample size, study setting or location, as long as the data needed for the analysis were available.

Our exclusion criteria were studies that had pediatric patients (age \<18 years old) and studies not published in the English language. If there were multiple publications from the same cohort and/or overlapping cohorts, data from the most recent and/or most appropriate comprehensive report were retained.

Data abstraction and quality assessment {#sec2-3}
---------------------------------------

Outcomes data from each study were abstracted onto a standardized form by a minimum of 2 authors, and 2 authors independently completed quality scoring. The Newcastle-Ottawa scale for cohort studies was used to assess the quality of studies \[[@ref10]\]. The details of this scoring system can be found in [Supplementary Table 1](#T1){ref-type="table"}.

###### 

Study quality assessment
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Outcomes assessed {#sec2-4}
-----------------

1\. Pooled rate of clinical success2. Pooled rate of *en bloc* tumor removal3. Pooled rate of high-grade dysplasia/intramucosal carcinoma (HGIC)4. Pooled rate of adverse events

Meta-regression analysis based on the tumor size was also performed. Clinical success was defined in 7 studies as complete endoscopic resection without local recurrence on follow-up examination. A single study defined clinical success as complete endoscopic resection and did not have follow up.

Statistical analysis {#sec2-5}
--------------------

The meta-analysis was carried out by calculating the pooled estimates following the methods suggested by DerSimonian and Laird. The random-effects model was used \[[@ref11]\]. When the incidence of an outcome was zero in a study, a continuity correction of 0.5 was added to the number of incident cases before statistical analysis \[[@ref12]\]. Heterogeneity was assessed by using the Cochran Q statistical test for heterogeneity, 95% prediction interval (PI) \[[@ref13]-[@ref15]\], and the *I*^2^ statistics \[[@ref16],[@ref17]\]. In the latter, values of \<30%, 30-60%, 61-75% and \>75% were considered to be of low, moderate, substantial and considerable heterogeneity, respectively \[[@ref18]\]. Publication bias was ascertained qualitatively, by visual inspection of a funnel plot, and quantitatively, by the Egger test \[[@ref19]-[@ref21]\]. A P value of \<0.05 was used *a priori* to define significance of differences between groups, as provided by the statistical software. All analyses were performed using Comprehensive Meta-Analysis (CMA) software, version 3 (BioStat, Englewood, NJ).

Results {#sec1-3}
=======

Search results and population characteristics {#sec2-6}
---------------------------------------------

From an initial 69 studies, 33 records were screened and 25 full-length articles were assessed. Eight studies were included in the final analysis \[[@ref22]-[@ref29]\]. A schematic diagram of the study selection is provided in [Supplementary Fig. 1](#F1){ref-type="fig"} and the population characteristics are described in [Table 1](#T2){ref-type="table"}.

![Study flow selection](AnnGastroenterol-33-379-g002){#F1}

###### 

Study and population characteristics
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Characteristics and quality of included studies {#sec2-7}
-----------------------------------------------

There were no multicenter or population based studies. Two studies had sample sizes \>40. The detailed assessment is summarized in [Supplementary Table 1](#T1){ref-type="table"}. Overall, 7 studies were considered to be of medium-quality and one study of high-quality. There were no low-quality studies.

Meta-analysis outcomes {#sec2-8}
----------------------

### Demographics and clinical success {#sec3-1}

There were 258 SNADET resected using the UEMR technique in 240 patients. The median patient age was 64.5 years. The mean tumor size was 19.4 mm (6-150).

Clinical success was reported in 8 studies that evaluated 240 patients. The pooled clinical success rate was 89.9% (95%CI 83.4-94.1). The *I*^2^ heterogeneity was 13% with a 95% PI of 76-96.

*En bloc* removal was reported in 6 studies that evaluated 221 patients and the achieved pooled rate was 84.6% of treated lesions (95%CI 75.5-90.7), with an *I*^2^ heterogeneity of 44% and 95% PI of 55-96. HGIC lesions reported in 7 studies, evaluated 151 patients. The pooled rate of HGIC lesions was 24.7% (95%CI 10.3-48.3), with an *I*^2^ heterogeneity of 70% and 95% PI of 2-87.

### Adverse events {#sec3-2}

Adverse events were reported in 8 studies that evaluated 240 patients. The pooled rate of adverse events was 6.9% (95%CI 2.5-17.9), with an *I*^2^ heterogeneity of 60% and 95% PI 1-63. This included 10 total adverse events, of which 9 were postoperative. There were no documented duodenal perforations. There were 7 patients with delayed bleeding. Of these patients, 6 were managed conservatively and 1 patient required endoscopic therapy. Other adverse outcomes included 1 patient with aspiration, 1 patient with postprocedural hyponatremia, and 1 patient who developed a duodenal stricture.

### Analysis based on tumor size {#sec3-3}

A meta-regression analysis was performed based on tumor size and the result was not significant, with a 2-sided P value of 0.47. This was performed to assess if there was any difference in clinical success based on tumor size, and no significant difference was found. The pooled results are summarized in [Table 2](#T3){ref-type="table"} and [Supplementary Fig. 2](#F2){ref-type="fig"}-[5](#F5){ref-type="fig"}.

###### 

Summary of pooled results
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![Forest plot, clinical success](AnnGastroenterol-33-379-g005){#F2}
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Validation of meta-analysis results {#sec2-9}
-----------------------------------

### Sensitivity analysis {#sec3-4}

We excluded each study, one at a time, and analyzed the effect on the main summary estimate. This was to assess whether any single study had a dominant effect on the meta-analysis outcome results. In this analysis, no single study significantly affected the outcome or the heterogeneity. This was performed for all outcomes.

Heterogeneity {#sec2-10}
-------------

We assessed the dispersion of the calculated rates using the PI and *I*^2^ percentage values. The PI gives an idea of the range of the dispersion and *I*^2^ tell us what proportion of the dispersion is true vs. chance \[[@ref15]\]. The calculated PIs are reported with the pooled results in [Table 2](#T3){ref-type="table"}. The PI was narrow with minimal heterogeneity in the pooled clinical success rate.

Publication bias {#sec2-11}
----------------

Publication bias assessment was carried out in relation to the primary outcomes in hand, which were the pooled rate of clinical success and pooled rate of *en bloc* removal. Based on visual inspection of the funnel plot, as well as quantitative measurement using the Egger regression test, there was no evidence of publication bias ([Supplementary Fig. 6](#F6){ref-type="fig"}, Eggers 2-tailed P=0.07, 0.6).
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Quality of evidence {#sec2-12}
-------------------

The GRADE working group approach was used to assess the quality of evidence \[[@ref30]\]. Observational studies start with a low-quality rating. This meta-analysis would be considered low quality of evidence, based on factors such as publication bias, heterogeneity, risk of bias and indirectness. These results are summarized in [Table 3](#T4){ref-type="table"}.

###### 

Summary of findings, quality of evidence
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Discussion {#sec1-4}
==========

In this study we present a systematic review and meta-analysis of the efficacy and safety of UEMR for SNADET. The pooled clinical success rate was 89.9% and the adverse event rate was 6.9%. The adverse events were generally self-limited, with no documented perforations. In addition, the *en bloc* resection rate was high at 84.6%. Meta-regression analysis showed no significant difference in clinical success based on tumor size. Based on these results, this technique appears to be a safe and effective method for endoscopic resection in the duodenum.

UEMR is an emerging technique for resection of superficial epithelial tumors in the gastrointestinal tract. The efficacy and safety of this technique is well described for resection of colonic polyps. In a recent systematic review and meta-analysis of UEMR for colorectal lesions, complete resection was achieved in 96.4% of lesions and the adverse event rate was low at 3.3%. As in our analysis, no cases of perforation, a feared complication of both EMR and ESD, were reported \[[@ref31]\].

Several factors make complete endoscopic resection of mucosal lesions difficult in the duodenum. These include a relatively narrow lumen, occasional luminal angulation, glandular formation precluding adequate submucosal lifting, and a thin muscular wall, which may increase the risk of perforation \[[@ref32]\]. The most commonly described technique is traditional EMR with submucosal injection. A recent systematic review of 10 studies showed a 93% rate of complete resection using traditional EMR. However, this technique was also associated with a pooled bleeding rate of 16%, a perforation rate of 1% and a recurrence rate of 15% \[[@ref33]\]. There was a delayed bleeding rate of 5% requiring endoscopic therapy, with one patient requiring surgical intervention.

Although less well studied, ESD is also a commonly utilized technique for the treatment of SNADET. This procedure is associated with less procedural bleeding than EMR; however, it carries a high perforation rate of 6-50%, limiting its utility in this setting \[[@ref34]-[@ref36]\]. In addition, this technique is not frequently employed in western countries, thus limiting its generalizability.

UEMR for SNADET has thus far shown promise. The pooled clinical success rate is comparable to both EMR and ESD. In addition, the adverse event profile appears acceptable, with no documented duodenal perforations and relatively benign post-procedural bleeding in previous studies.

There are several strengths to this study. There were no low-quality studies included. In addition, there was minimal heterogeneity and no publication bias found. However, the study also has limitations. Given the novelty of UEMR for SNADET, only 8 studies were included for analysis. In addition, all of the studies were single-center observational studies, although the majority were prospective. There was also a wide range in the mean size of tumor resection (6-150 mm). Finally, 2 studies did not report on rate of *en bloc* resection, 1 study did not report on HGIC, and 1 study did not report follow-up endoscopic examinations. Regardless, there is a relative paucity of data regarding endoscopic resection of SNADET and this study supports using UEMR in this setting.

In conclusion, UEMR appears to be an effective technique for SNADET. In addition, the adverse event profile is acceptable, with no documented duodenal perforation. Based on these results, this technique should be considered as a therapeutic option for resection of SNADET.

###### Summary Box

**What is already known:**

• The incidence of superficial non-ampullary duodenal epithelial tumors (SNADET) is increasing• Commonly used techniques for endoscopic removal including traditional endoscopic mucosal resection (EMR) and endoscopic submucosal dissection both have limitations in this setting• Underwater EMR (UEMR) is an emerging technique for endoscopic resection; previous studies involving the colorectum have shown excellent efficacy and safety

**What the new findings are:**

• UEMR has high pooled rates of clinical success and *en bloc* removal for SNADET• UEMR has an acceptable pooled rate of adverse events, with no documented duodenal perforations• UEMR is an effective technique for endoscopic removal of SNADET
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Literature search strategy:

Strategy: {#sec2-15}
=========

**PubMed (15)**

((Underwater AND endoscop\*) OR "UW-EMR" OR UEMR) AND (duodenum OR duodenal) Limit to English

**Embase (26)**

(underwater AND endoscop\* OR "UW-EMR" OR uemr) AND ('duodenum'/exp OR duodenum\* OR duodena\*)AND \[english\]/lim

**Scopus (16)**

(TITLE-ABS-KEY ((underwater AND endoscop\*) OR "UW-EMR" OR uemr) AND TITLE-ABS-KEY (duoden\*))
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###### 

MOOSE Checklist for meta-analyses of observational studies
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